WHO GMP approved Oncology facility Bortezomib, 179324-69-7 Oncology API has the capacity to manufacturers & Suppliers in India, highly complex, highly potent, semi-synthetic APIs & is committed to Excellence in Product Quality. https://www.kekulepharma.com/products/oncology-apis/bortezomib